Randomized Phase II Study of Bortezomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in Multiple Myeloma.

Condition:   Multiple Myeloma Intervention:   Drug: Renalidomide, Velcade, Dexamethasone Sponsor:   Samsung Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials